The popularity of Viagra initially drove a period of growth for pharma, but recent changes present a complicated outlook for shareholders. Generic alternatives are eating into profits, and continued patent challenges https://jasperyqky742485.blog2news.com/41700039/sildenafil-and-pharma-a-volatile-bet